Listen to the CEO and Founder of Attomarker, Professor Shaw, discussing the AMVAIS test on Dr Binita Kane’s Fireside Chat.
For thousands of years clinicians have had to make diagnoses based on symptoms alone. More recently we have had blood tests, but the results often arrive too late or are too uni-dimensional.
Attomarker offers rapid personalised multi-dimensional diagnosis that enables earlier treatment designed to meet your unique, individual healthcare needs.
High quality diagnosis, which can be mapped against symptoms using AI, will reach beyond the laboratory and be accessible to everyone, in clinics, pharmacies and at home.
*Clinican-led named-patient research test
